m+Medelevator.RU
← Поиск публикаций
Journal of oral biology and craniofacial research · 2026

Comparison of lip repositioning and lip repositioning with botulinum toxin application in gummy smile treatment.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Keles Mert, Sen Dilek Ozkan, Oncu Elif

Аннотация

BACKGROUND: This study aimed to compare the effects of lip repositioning surgery alone versus its combination with botulinum toxin type A injection in reducing gingival display and to evaluate the esthetic stability of both approaches over a 1-year follow-up.

METHODS: A retrospective analysis was conducted using clinical records of 29 patients with excessive gingival display. Group A (n = 14) underwent lip repositioning surgery alone, while Group B (n = 15) received the same surgery followed by botulinum toxin injection. Gingival visibility was assessed from archived clinical records at baseline and at 1, 3, and 12 months postoperatively, with available clinical photographs reviewed solely as supplementary documentation. Statistical analyses were performed according to data distribution.

RESULTS: Both groups showed significant within-group reductions in gingival display (p < 0.001). At 3 months, Group B demonstrated a significantly greater improvement (p < 0.001), indicating a short-term additive effect of botulinum toxin. However, by 12 months, the difference between groups was not statistically significant (p = 0.134), and surgical outcomes remained stable.

CONCLUSION: Within the limitations of a retrospective design and the variability of clinical records, lip repositioning surgery provided predictable and long-term esthetic results in managing gummy smile. While botulinum toxin may enhance short-term outcomes, its temporary effect limits long-term benefits. Treatment planning should consider both objective outcomes and patient esthetic expectations.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты